---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-112671"
form_type: "8-K"
ticker: "GUTS"
cik: "0001572616"
company_name: "FRACTYL HEALTH, INC."
filed_at: "2025-09-03T23:59:59+00:00"
generated_at: "2026-05-17T08:31:28.131285+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Fractyl Health appoints Dr. Christopher Thompson and Ian Sheffield to board; Amy Schulman resigns

## Summary
- Christopher Thompson, M.D. appointed as Class I director effective Sept 2, 2025.
- Ian Sheffield appointed as Class II director and to audit committee effective Sept 2, 2025.
- Each receives $43,500 annual retainer; Sheffield gets additional $10,000 for audit committee; initial option for 45,000 shares vesting over 3 years.
- Amy W. Schulman resigned as Class I director and from nominating committee effective Sept 2, 2025; no dispute with company.

## SEC filing metadata
- accession: 0000950170-25-112671
- form_type: 8-K
- ticker: GUTS
- cik: 0001572616
- company_name: FRACTYL HEALTH, INC.
- filed_at: 2025-09-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1572616/000095017025112671/0000950170-25-112671-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1572616/000095017025112671/guts-20250829.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-112671
- JSON: https://secwatch.observer/filing/0000950170-25-112671.json
- Plain text: https://secwatch.observer/filing/0000950170-25-112671.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.